Literature DB >> 1327508

Primary immunodeficiencies: genetic risk factors for lymphoma.

A H Filipovich1, A Mathur, D Kamat, R S Shapiro.   

Abstract

It has been estimated that up to 25% of patients with certain genetically determined immunodeficiencies will develop tumors, primarily B-cell lymphomas, during their lifetime. Epstein-Barr virus appears to be an important cofactor in the development of lymphoproliferative disorders in patients with primary immunodeficiencies, as well as acquired immunodeficiencies. Additionally, host defects in immunoregulation and/or gene rearrangement, which are features of certain primary immunodeficiencies, probably contribute to the risk of lymphomagenesis in patients at risk.

Entities:  

Mesh：

Year:  1992        PMID： 1327508

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  39 in total

1.  Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairs.

Authors:  Jun Wang; Thomas M Mack; Ann S Hamilton; Amie E Hwang; Bharat N Nathwani; Kamil Masood; Laura H Buchanan; Leslie Bernstein; Dennis M Deapen; Otoniel Martínez-Maza; Wendy Cozen
Journal:  Am J Epidemiol       Date:  2015-08-12       Impact factor: 4.897

2.  Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.

Authors:  T Mitterlechner; M Fiegl; H Mühlböck; W Oberaigner; S Dirnhofer; A Tzankov
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

3.  Occupation and malignant lymphoma: a population based case control study in Germany.

Authors:  B Mester; A Nieters; E Deeg; G Elsner; N Becker; A Seidler
Journal:  Occup Environ Med       Date:  2006-01       Impact factor: 4.402

4.  Immune disorders and susceptibility to neoplasms.

Authors:  Om Prakash; Javed Gill; Gist Farr
Journal:  Ochsner J       Date:  2002

5.  Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.

Authors:  Jie Jiao; Tongzhang Zheng; Qing Lan; Yingtai Chen; Qian Deng; Xiaofeng Bi; Christopher Kim; Theodore Holford; Brian Leaderer; Peter Boyle; Yue Ba; Zhaolin Xia; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Eur J Cancer Prev       Date:  2012-11       Impact factor: 2.497

Review 6.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09

Review 7.  Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A J Swerdlow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

8.  Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice.

Authors:  E Szomolanyi-Tsuda; P L Dundon; I Joris; L D Shultz; B A Woda; R M Welsh
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

Review 9.  Mechanisms involved in Burkitt's tumor formation.

Authors:  M R Campanero
Journal:  Clin Transl Oncol       Date:  2008-05       Impact factor: 3.405

10.  Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2.

Authors:  Aaron E Hoffman; Tongzhang Zheng; Richard G Stevens; Yue Ba; Yawei Zhang; Derek Leaderer; Chunhui Yi; Theodore R Holford; Yong Zhu
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.